ARCore vs. ARkit, VR gateway drugs, and early stage VR/AR strategies. These are a few topics in the latest ARtillry Weekly.
As its name implies, it will be published weekly with a mix of original insights and curated articles. View the web version here, or subscribe here. It’s AR & VR Insights for your Inbox.
For a deeper dive on AR & VR insights, see ARtillry’s new intelligence subscription, and sign up for the free ARtillry Weekly newsletter.
Disclosure: ARtillry has no financial stake in the companies mentioned in this article, nor received payment for its production. Disclosure and ethics policy can be seen here.